Department of Physiology, Medical College of Georgia, Augusta, GA, USA.
J Sex Med. 2010 Nov;7(11):3620-34. doi: 10.1111/j.1743-6109.2010.02000.x. Epub 2010 Aug 30.
Diabetes mellitus (DM) is a risk factor for erectile dysfunction (ED). Although type 2 DM is responsible for 90-95% diabetes cases, type 1 DM experimental models are commonly used to study diabetes-associated ED.
Goto-Kakizaki (GK) rat model is relevant to ED studies since the great majority of patients with type 2 diabetes display mild deficits in glucose-stimulated insulin secretion, insulin resistance, and hyperglycemia. We hypothesized that GK rats display ED which is associated with decreased nitric oxide (NO) bioavailability.
Wistar and GK rats were used at 10 and 18 weeks of age. Changes in the ratio of intracavernosal pressure/mean arterial pressure (ICP/MAP) after electrical stimulation of cavernosal nerve were determined in vivo. Cavernosal contractility was induced by electrical field stimulation (EFS) and phenylephrine (PE). In addition, nonadrenergic-noncholinergic (NANC)- and sodium nitroprusside (SNP)-induced relaxation were determined. Cavernosal neuronal nitric oxide synthase (nNOS) and endothelial nitric oxide synthase (eNOS) mRNA and protein expression were also measured.
GK diabetic rats display ED associated with decreased cavernosal expression of eNOS protein.
GK rats at 10 and 18 weeks demonstrated impaired erectile function represented by decreased ICP/MAP responses. Ten-week-old GK animals displayed increased PE responses and no changes in EFS-induced contraction. Conversely, contractile responses to EFS and PE were decreased in cavernosal tissue from GK rats at 18 weeks of age. Moreover, GK rats at 18 weeks of age displayed increased NANC-mediated relaxation, but not to SNP. In addition, ED was associated with decreased eNOS protein expression at both ages.
Although GK rats display ED, they exhibit changes in cavernosal reactivity that would facilitate erectile responses. These results are in contrast to those described in other experimental diabetes models. This may be due to compensatory mechanisms in cavernosal tissue to overcome restricted pre-penile arterial blood supply or impaired veno-occlusive mechanisms.
糖尿病(DM)是勃起功能障碍(ED)的一个危险因素。虽然 2 型 DM 占糖尿病病例的 90-95%,但常使用 1 型 DM 实验模型来研究与糖尿病相关的 ED。
Goto-Kakizaki(GK)大鼠模型与 ED 研究相关,因为大多数 2 型糖尿病患者表现出葡萄糖刺激的胰岛素分泌、胰岛素抵抗和高血糖的轻度缺陷。我们假设 GK 大鼠表现出 ED,其与一氧化氮(NO)生物利用度降低有关。
10 周和 18 周龄时使用 Wistar 和 GK 大鼠。通过电刺激海绵体神经来确定体内海绵体内压/平均动脉压(ICP/MAP)比值的变化。用电场刺激(EFS)和苯肾上腺素(PE)诱导海绵体收缩。此外,还测定了非肾上腺素非胆碱能(NANC)和硝普钠(SNP)诱导的松弛。还测量了海绵体神经元型一氧化氮合酶(nNOS)和内皮型一氧化氮合酶(eNOS)mRNA 和蛋白表达。
GK 糖尿病大鼠表现出与海绵体 eNOS 蛋白表达降低相关的 ED。
10 周和 18 周时的 GK 大鼠表现出勃起功能受损,表现为 ICP/MAP 反应降低。10 周龄的 GK 动物表现出对 PE 反应增加,而 EFS 诱导的收缩无变化。相反,18 周龄 GK 大鼠的海绵体组织对 EFS 和 PE 的收缩反应降低。此外,18 周龄的 GK 大鼠表现出增加的 NANC 介导的松弛,但对 SNP 无反应。此外,ED 与两个年龄段的 eNOS 蛋白表达降低有关。
尽管 GK 大鼠表现出 ED,但它们表现出海绵体反应的变化,这有利于勃起反应。这些结果与其他实验性糖尿病模型中描述的结果相反。这可能是由于海绵体组织中的代偿机制,以克服阴茎前动脉血液供应受限或受损的静脉闭塞机制。